The Circular RNA CircEIF3M Promotes Breast Cancer Progression by Promoting Cyclin D1 Expression

Overview

Journal Aging (Albany NY)

Specialty Geriatrics

Date 2020 Jul 12

PMID 32652519

Citations 8

Authors

Xiujuan Li

Zhaojun Ren

YuFeng Yao

Jun Bao

Qiao Yu

Affiliations

Soon will be listed here.

Abstract

We investigated the function of circular RNA circEIF3M (hsa_circ_0003119) in triple-negative breast cancer. The expression profiles of circRNAs in 3 specimens of triple-negative breast cancer tissues with adjacent nontumor tissues were analyzed by RNA-sequencing. We verified the oncogenic role of circEIF3M in triple-negative breast cancer through a series of biological function experiments. It was found that circEIF3M was markedly upregulated in triple-negative breast cancer as compared to adjacent nontumor tissue, and that circEIF3M promoted triple-negative breast cancer cell proliferation, migration, and invasion. Mechanistic analysis indicated that circEIF3M may act as a competing endogenous RNA for miR-33a that relieves the inhibitory effect of miR-33a on its target cyclin D1. These findings showed that circEIF3M promotes triple-negative breast cancer progression via the circEIF3M/ miR-33a/ cyclin D1 axis.

Citing Articles

Circular RNA-mediated miRNA sponge & RNA binding protein in biological modulation of breast cancer.

Zhu J, Li Q, Wu Z, Xu W, Jiang R Noncoding RNA Res. 2024; 9(1):262-276.

PMID: 38282696 PMC: 10818160. DOI: 10.1016/j.ncrna.2023.12.005.

Regulatory miRNAs, circRNAs and lncRNAs in cell cycle progression of breast cancer.

Chen H, Xie G, Luo Q, Yang Y, Hu S Funct Integr Genomics. 2023; 23(3):233.

PMID: 37432486 DOI: 10.1007/s10142-023-01130-z.

Combined analyses of RNA-sequence and Hi-C along with GWAS loci-A novel approach to dissect keloid disorder genetic mechanism.

Huang J, Zhou X, Wang W, Zhou G, Zhang W, Gao Z PLoS Genet. 2022; 18(6):e1010168.

PMID: 35709140 PMC: 9202908. DOI: 10.1371/journal.pgen.1010168.

The Regulation Network and Clinical Significance of Circular RNAs in Breast Cancer.

Xu J, Chen X, Sun Y, Shi Y, Teng F, Lv M Front Oncol. 2021; 11:691317.

PMID: 34307155 PMC: 8299466. DOI: 10.3389/fonc.2021.691317.

Bergamottin Induces DNA Damage and Inhibits Malignant Progression in Melanoma by Modulating miR-145/Cyclin D1 Axis.

Zhao Z, Liao N Onco Targets Ther. 2021; 14:3769-3781.

PMID: 34168462 PMC: 8216741. DOI: 10.2147/OTT.S275322.

References

Glazar P, Papavasileiou P, Rajewsky N . circBase: a database for circular RNAs. RNA. 2014; 20(11):1666-70. PMC: 4201819. DOI: 10.1261/rna.043687.113. View

Chen Y, Li C, Tan C, Liu X . Circular RNAs: a new frontier in the study of human diseases. J Med Genet. 2016; 53(6):359-65. DOI: 10.1136/jmedgenet-2016-103758. View

Liang C, Yu X, Guo X, Sun M, Wang Z, Song Y . MicroRNA-33a-mediated downregulation of Pim-3 kinase expression renders human pancreatic cancer cells sensitivity to gemcitabine. Oncotarget. 2015; 6(16):14440-55. PMC: 4546478. DOI: 10.18632/oncotarget.3885. View

Ghosal S, Das S, Sen R, Basak P, Chakrabarti J . Circ2Traits: a comprehensive database for circular RNA potentially associated with disease and traits. Front Genet. 2013; 4:283. PMC: 3857533. DOI: 10.3389/fgene.2013.00283. View

Liu P, Chen B, Gu Y, Liu Q . PNMA1, regulated by miR-33a-5p, promotes proliferation and EMT in hepatocellular carcinoma by activating the Wnt/β-catenin pathway. Biomed Pharmacother. 2018; 108:492-499. DOI: 10.1016/j.biopha.2018.09.059. View

Mirzania M, Safaee S, Shahi F, Jahanzad I, Zahedi G, Mehdizadeh R . Treatment Outcomes and Clinicopathologic Characteristics of Triple-Negative Breast Cancer: A Report from Cancer Institute of Iran. Int J Hematol Oncol Stem Cell Res. 2017; 11(1):37-42. PMC: 5338280. View

Zhang C, Zhang Y, Ding W, Lin Y, Huang Z, Luo Q . MiR-33a suppresses breast cancer cell proliferation and metastasis by targeting ADAM9 and ROS1. Protein Cell. 2015; 6(12):881-9. PMC: 4656205. DOI: 10.1007/s13238-015-0223-8. View

Xie M, Zhao F, Zou X, Jin S, Xiong S . The association between CCND1 G870A polymorphism and colorectal cancer risk: A meta-analysis. Medicine (Baltimore). 2017; 96(42):e8269. PMC: 5662386. DOI: 10.1097/MD.0000000000008269. View

Han D, Li J, Wang H, Su X, Hou J, Gu Y . Circular RNA circMTO1 acts as the sponge of microRNA-9 to suppress hepatocellular carcinoma progression. Hepatology. 2017; 66(4):1151-1164. DOI: 10.1002/hep.29270. View

10.

Qu S, Yang X, Li X, Wang J, Gao Y, Shang R . Circular RNA: A new star of noncoding RNAs. Cancer Lett. 2015; 365(2):141-8. DOI: 10.1016/j.canlet.2015.06.003. View

11.

Kong Y, Sheng X, Wu X, Yan J, Ma M, Yu J . Frequent Genetic Aberrations in the CDK4 Pathway in Acral Melanoma Indicate the Potential for CDK4/6 Inhibitors in Targeted Therapy. Clin Cancer Res. 2017; 23(22):6946-6957. DOI: 10.1158/1078-0432.CCR-17-0070. View

12.

Hansen T, Jensen T, Clausen B, Bramsen J, Finsen B, Damgaard C . Natural RNA circles function as efficient microRNA sponges. Nature. 2013; 495(7441):384-8. DOI: 10.1038/nature11993. View

13.

Moises J, Navarro A, Santasusagna S, Vinolas N, Molins L, Ramirez J . NKX2-1 expression as a prognostic marker in early-stage non-small-cell lung cancer. BMC Pulm Med. 2017; 17(1):197. PMC: 5727907. DOI: 10.1186/s12890-017-0542-z. View

14.

Yang F, Wang Y, Li Q, Cao L, Sun Z, Jin J . Intratumor heterogeneity predicts metastasis of triple-negative breast cancer. Carcinogenesis. 2017; 38(9):900-909. DOI: 10.1093/carcin/bgx071. View

15.

Cheng J, Metge F, Dieterich C . Specific identification and quantification of circular RNAs from sequencing data. Bioinformatics. 2015; 32(7):1094-6. DOI: 10.1093/bioinformatics/btv656. View

16.

Munirah M, Siti-Aishah M, Reena M, Sharifah N, Rohaizak M, Norlia A . Identification of different subtypes of breast cancer using tissue microarray. Rom J Morphol Embryol. 2011; 52(2):669-77. View

17.

Kumar L, Shamsuzzama , Haque R, Baghel T, Nazir A . Circular RNAs: the Emerging Class of Non-coding RNAs and Their Potential Role in Human Neurodegenerative Diseases. Mol Neurobiol. 2016; 54(9):7224-7234. DOI: 10.1007/s12035-016-0213-8. View

18.

Kulcheski F, Christoff A, Margis R . Circular RNAs are miRNA sponges and can be used as a new class of biomarker. J Biotechnol. 2016; 238:42-51. DOI: 10.1016/j.jbiotec.2016.09.011. View

19.

Li X, Ji M, Zhong S, Zha Q, Xu J, Zhao J . MicroRNA-34a modulates chemosensitivity of breast cancer cells to adriamycin by targeting Notch1. Arch Med Res. 2012; 43(7):514-21. DOI: 10.1016/j.arcmed.2012.09.007. View

20.

Xin Z, Ma Q, Ren S, Wang G, Li F . The understanding of circular RNAs as special triggers in carcinogenesis. Brief Funct Genomics. 2016; 16(2):80-86. DOI: 10.1093/bfgp/elw001. View